BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 12422152)

  • 1. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation.
    Wieczorek SJ; Wu AH; Christenson R; Krishnaswamy P; Gottlieb S; Rosano T; Hager D; Gardetto N; Chiu A; Bailly KR; Maisel A
    Am Heart J; 2002 Nov; 144(5):834-9. PubMed ID: 12422152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.
    Maisel AS; McCord J; Nowak RM; Hollander JE; Wu AH; Duc P; Omland T; Storrow AB; Krishnaswamy P; Abraham WT; Clopton P; Steg G; Aumont MC; Westheim A; Knudsen CW; Perez A; Kamin R; Kazanegra R; Herrmann HC; McCullough PA;
    J Am Coll Cardiol; 2003 Jun; 41(11):2010-7. PubMed ID: 12798574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide for diagnosis and treatment of congestive heart failure.
    Kuster GM; Tanner H; Printzen G; Suter TM; Mohacsi P; Hess OM
    Swiss Med Wkly; 2002 Dec; 132(43-44):623-8. PubMed ID: 12587046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
    Lee SC; Stevens TL; Sandberg SM; Heublein DM; Nelson SM; Jougasaki M; Redfield MM; Burnett JC
    J Card Fail; 2002 Jun; 8(3):149-54. PubMed ID: 12140807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
    Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
    Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide.
    McNairy M; Gardetto N; Clopton P; Garcia A; Krishnaswamy P; Kazanegra R; Ziegler M; Maisel AS
    Am Heart J; 2002 Mar; 143(3):406-11. PubMed ID: 11868044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure.
    Kato M; Kinugawa T; Ogino K; Endo A; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Intern Med; 2000 Oct; 248(4):309-15. PubMed ID: 11086641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
    Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.
    Dao Q; Krishnaswamy P; Kazanegra R; Harrison A; Amirnovin R; Lenert L; Clopton P; Alberto J; Hlavin P; Maisel AS
    J Am Coll Cardiol; 2001 Feb; 37(2):379-85. PubMed ID: 11216950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.
    Harrison A; Morrison LK; Krishnaswamy P; Kazanegra R; Clopton P; Dao Q; Hlavin P; Maisel AS
    Ann Emerg Med; 2002 Feb; 39(2):131-8. PubMed ID: 11823766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea.
    Steg PG; Joubin L; McCord J; Abraham WT; Hollander JE; Omland T; Mentré F; McCullough PA; Maisel AS
    Chest; 2005 Jul; 128(1):21-9. PubMed ID: 16002911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.
    Daggubati S; Parks JR; Overton RM; Cintron G; Schocken DD; Vesely DL
    Cardiovasc Res; 1997 Nov; 36(2):246-55. PubMed ID: 9463636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical detection of left-ventricular systolic dysfunction.
    McDonagh TA; Robb SD; Murdoch DR; Morton JJ; Ford I; Morrison CE; Tunstall-Pedoe H; McMurray JJ; Dargie HJ
    Lancet; 1998 Jan; 351(9095):9-13. PubMed ID: 9433422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic Peptide predicts clinical presentations and ventricular overloading in patients with heart failure.
    Joung BY; Park BE; Kim DS; Hong BK; Kim DY; Cho YH; Lee SH; Yoon YW; Kim HS; Kim JH; Kwon HM
    Yonsei Med J; 2003 Aug; 44(4):623-34. PubMed ID: 12950118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.
    Stanton E; Hansen M; Wijeysundera HC; Kupchak P; Hall C; Rouleau JL;
    Eur J Heart Fail; 2005 Jun; 7(4):557-65. PubMed ID: 15921795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between immunoradiometric and fluorimetric brain natriuretic peptide determination in patients with congestive heart failure.
    Feola M; Valeri L; Menditto E; Nervo E; Bianco F; Aspromonte N; Valle R; Visconti G
    J Endocrinol Invest; 2010 Sep; 33(8):554-8. PubMed ID: 20160469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.